Contineum Therapeutics Inc. Class A Common Stock
8.68 USD −0.36 −3.98%
Last update: Nov 20, 2026 12:00 AM UTC
Forecasts
Technical rating
- Analysts' price target
- 21.50 USD
- Distance to target
- +147.70%
The price target is the average published by analysts; the technical rating sums up indicators of the daily chart. Neither is investment advice.
Trading involves risk. Nothing on this site is financial advice.